V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 230000469 | 230000274 | 1.6 | 56.8 | Neo-adjuvant (N) | 2014-04-15 | 2014-05-06 | Fluorouracil+Mitomycin+RT (Anal Ca) | N | N | 230004103 | CAPECITABINE + MITOMYCIN + RT |
| 230000470 | 230000275 | 1.75 | 131 | Disease modification (D) | 2015-04-29 | 2015-05-13 | ARISTOTLE TRIAL | N | Y | 230004114 | CARBOPLATIN |
| 230000471 | 230000276 | 1.76 | 92.2 | Adjuvant (A) | 2014-09-10 | 2014-09-12 | Capecitabine 35days + RT | N | N | 230004117 | BENDAMUSTINE + RITUXIMAB |
| 230000472 | 230000277 | 1.65 | 109 | Adjuvant (A) | 2015-06-05 | 2015-08-01 | Capecitabine | 02 | N | 230004131 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 230000473 | 230000277 | 1.69 | 85.5 | Adjuvant (A) | 2018-02-21 | 2018-03-03 | Irinotecan | 99 | N | 230004131 | CABOZANTINIB |
| 230000474 | 230000277 | null | null | Not known (9) | 2016-11-03 | 2016-10-30 | Capecitabine | null | N | 230004131 | CAPECITABINE + GEMCITABINE |
| 230000475 | 230000278 | 1.6 | 49.4 | Adjuvant (A) | 2016-05-09 | 2016-05-18 | FEC 60 or 75 | N | N | 230004182 | DOCETAXEL |
| 230000476 | 230000279 | 1.63 | null | Not known (9) | 2014-08-07 | 2014-08-10 | TEMOZOLOMIDE | 2 | N | 230004221 | CHLORAMBUCIL + RITUXIMAB |
| 230000477 | 230000279 | 1.63 | 112 | Disease modification (D) | 2016-11-22 | 2016-12-27 | Sorafenib | N | N | 230004221 | FLUOROURACIL + RT |
| 230000478 | 230000280 | 1.66 | 66.5 | Palliative (P) | 2015-06-12 | 2015-06-19 | Rituximab | N | N | 230004260 | PACLITAXEL |
| 230000479 | 230000280 | null | null | Palliative (P) | null | 2017-12-01 | Irinotecan + Modified De Gramont | null | N | 230004260 | GEMCARBO |
| 230000480 | 230000280 | null | null | Adjuvant (A) | 2014-06-28 | 2014-07-05 | Capecitabine 35days + RT | N | null | 230004260 | ABIRATERONE |
| 230000481 | 230000281 | 1.77 | 80 | null | 2014-04-14 | 2014-04-14 | Docetaxel 75mg/m2 (21 day) | N | null | 230004285 | FEC |
| 230000482 | 230000282 | 1.8 | null | Adjuvant (A) | 2014-02-06 | 2014-02-15 | Carboplatin + Pemetrexed | 2 | N | 230004293 | SORAFENIB |
| 230000483 | 230000282 | null | 69.799 | Neo-adjuvant (N) | 2014-01-15 | 2014-02-11 | FLUOROURACIL | null | N | 230004293 | CAPECITABINE + RT |
| 230000485 | 230000284 | 1.8 | null | Palliative (P) | null | 2015-05-28 | Cisplatin + Docetaxel | N | null | 230004393 | CISPLATIN + VINORELBINE |
| 230000486 | 230000285 | 1.8 | 65 | null | 2016-07-04 | 2016-07-06 | Carboplatin + Etoposide IV 3 day | 02 | null | 230004395 | PEMBROLIZUMAB |
| 230000487 | 230000286 | null | 64.25 | Palliative (P) | 2016-03-01 | 2016-03-26 | Fluorouricil + Folonic Acid (MdG) | 02 | N | 230004403 | DOCETAXEL |
| 230000488 | 230000287 | 1.6 | 61 | Palliative (P) | 2015-03-15 | 2015-03-30 | EOX | N | N | 230004435 | DOXORUBICIN |
| 230000489 | 230000288 | 1.66 | 79 | Adjuvant (A) | 2015-10-28 | 2015-11-12 | Fluorouracil+Mitomycin+RT (Bladder) | 2 | N | 230004445 | FLUOROURACIL |
| 230000490 | 230000289 | null | 65.3 | Curative (C) | 2015-03-15 | 2015-03-22 | Capecitabine | 02 | Y | 230004514 | CARBOPLATIN + VINORELBINE |
| 230000491 | 230000289 | 1.68 | 80 | Adjuvant (A) | 2018-05-16 | 2018-05-16 | Capecitabine | 02 | N | 230004514 | CAPECITABINE + MITOMYCIN + RT |
| 230000492 | 230000289 | 1.78 | 84.1 | Adjuvant (A) | 2014-11-18 | 2014-11-19 | CARBOPLATIN + ETOPOSIDE | 02 | N | 230004514 | DOCETAXEL |
| 230000493 | 230000290 | null | 71.5 | Palliative (P) | 2015-03-26 | 2015-03-26 | Sorafenib | N | null | 230004550 | CISPLATIN + GEMCITABINE |
| 230000494 | 230000291 | 1.63 | 76 | Adjuvant (A) | 2017-11-29 | 2017-12-12 | CAPECITABINE + MITOMYCIN + RT | N | N | 230004560 | VANDETANIB |
| 230000495 | 230000291 | null | 87 | null | 2014-09-24 | 2014-09-30 | Capecitabine 35days + RT | N | null | 230004560 | CISPLATIN + DOXORUBICIN |
| 230000496 | 230001495 | 0 | 79.5 | Curative (C) | 2013-05-24 | 2013-06-18 | ECarboF | 02 | null | 230004622 | DOCETAXEL |
| 230000497 | 230000292 | 1.5 | 71 | Palliative (P) | 2018-05-17 | 2018-05-17 | Rituximab | 02 | N | 230004650 | MITOMYCIN INTRAVESICULAR |
| 230000498 | 230000293 | null | 69 | Disease modification (D) | 2013-09-28 | 2013-11-02 | Fluorouracil+Mitomycin+RT (Anal Ca) | N | N | 230004652 | FLUOROURACIL + MITOMYCIN + RT |
| 230000499 | 230000293 | 1.76 | 97.1 | Palliative (P) | 2016-11-01 | 2016-11-01 | Trial Unspecified | N | N | 230004652 | CTD |
| 230000500 | 230000294 | 1.84 | 92.9 | Palliative (P) | 2013-12-06 | 2013-12-14 | Cisplatin + Doxorubicin | N | N | 230004725 | SORAFENIB |
| 230000501 | 230000295 | 1.73 | 61 | Palliative (P) | 2014-11-20 | 2014-11-26 | Capecitabine + Oxaliplatin 21day | 02 | N | 230004751 | PAZOPANIB |
| 230000502 | 230000295 | 0 | 84.9 | Adjuvant (A) | 2016-07-19 | 2016-08-02 | Capecitabine + Oxaliplatin 21day | 02 | N | 230004751 | GEMCITABINE |
| 230000503 | 230000296 | 1.82 | null | Adjuvant (A) | 2017-12-10 | 2017-12-24 | Irinotecan | N | null | 230004777 | GEMCITABINE |
| 230000504 | 230000296 | null | 56.6 | Palliative (P) | 2019-02-13 | 2019-02-28 | Capecitabine | N | null | 230004777 | AC |
| 230000505 | 230000296 | 1.55 | 59.3 | Palliative (P) | 2013-06-05 | 2013-06-05 | CARBOPLATIN + PACLITAXEL | N | N | 230004777 | RITUXIMAB |
| 230000506 | 230000297 | 1.7 | 53 | Not known (9) | null | 2016-01-08 | CHOP R - 21 days | 99 | null | 230004832 | CARBOPLATIN + PEMETREXED |
| 230000507 | 230000297 | 1.63 | 64 | Curative (C) | null | 2016-04-08 | Oxaliplatin + Modified de Gramont | N | Y | 230004832 | SORAFENIB |
| 230000508 | 230000297 | 1.58 | 69.1 | Adjuvant (A) | 2013-06-11 | 2013-06-18 | EC | N | N | 230004832 | VANDETANIB |
| 230000509 | 230000297 | null | null | Palliative (P) | 2016-02-02 | 2016-02-10 | FLUOROURACIL + OXALIPLATIN | N | N | 230004832 | VANDETANIB |
| 230000510 | 230000298 | 1.7 | 69.4 | Adjuvant (A) | null | 2017-09-03 | Cisplatin + Radiotherapy | N | N | 230004936 | CISPLATIN + DOXORUBICIN |
| 230000511 | 230000299 | 1.68 | 69.45 | Not known (9) | 2015-12-17 | 2015-12-18 | CAPECITABINE + OXALIPLATIN | N | N | 230004940 | DOXORUBICIN |
| 230000512 | 230000299 | 1.7 | 68.3 | Adjuvant (A) | 2017-01-09 | 2017-01-11 | Fluorouricil + Folonic Acid (MdG) | N | N | 230004940 | CAPECITABINE + OXALIPLATIN |
| 230000513 | 230000300 | 1.6 | 67.4 | Palliative (P) | 2011-11-16 | 2018-04-10 | Capecitabine | 02 | N | 230004994 | CARBOPLATIN + PEMETREXED |
| 230000514 | 230000301 | 1.55 | null | Disease modification (D) | 2014-03-14 | 2014-04-03 | CAPECITABINE + MITOMYCIN + RT | 02 | null | 230005007 | EC |
| 230000515 | 230000302 | null | -1 | Adjuvant (A) | 2013-06-27 | 2013-07-13 | DOXORUBICIN | N | Y | 230005053 | CISPLATIN + ETOPOSIDE |
| 230000516 | 230001163 | 1.8 | 84.6 | Not known (9) | 2018-02-22 | 2018-03-07 | Capecitabine + Oxaliplatin 14day | N | N | 230005078 | MITOMYCIN INTRAVESICULAR |
| 230000517 | 230001163 | 1.65 | 0 | Adjuvant (A) | 2018-12-09 | 2018-12-12 | Carboplatin AUC 2 - 5 | 02 | N | 230005078 | CISPLATIN + DOXORUBICIN |
| 230000518 | 230000303 | 1.68 | 47.5 | Palliative (P) | 2015-07-26 | 2015-07-26 | Fluorouracil+Mitomycin+RT (Anal Ca) | 02 | null | 230005102 | CAPECITABINE + OXALIPLATIN |
| 230000519 | 230000303 | 1.76 | 69.6 | Adjuvant (A) | 2015-07-20 | 2015-07-21 | Docetaxel | N | N | 230005102 | CAPECITABINE + OXALIPLATIN |